Mark W Kieran, MD, PhD
Dana-Farber Cancer Institute, Children's Hospital Boston
1
0
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Nicolas LEVY, MD
Assistance Publique des Hopitaux de Marseille
Shared therapeutic areas:
Mark W Kieran, MD, PhD
Dana-Farber Cancer Institute; Boston Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
William A Gahl, M.D.
National Human Genome Research Institute (NHGRI)
Shared therapeutic areas:
Monica Kleinman, M.D.
Boston Children's Hospital
Shared therapeutic areas:
Mark Kieran, MD, PhD
Children's Hospital Boston/ Dana-Farber Cancer Instittue
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
All 1 trials loaded